Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
ALX Oncology Pairs Lead Asset with Keytruda in HNSCC Study
BioSpace
Tue, 09/22/20 - 12:06 pm
ALX Oncology
Merck
head and neck cancer
ALX148
Keytruda
ESMO: Roche's mixed results put Tecentriq's triple-negative breast cancer use into question
Fierce Pharma
Sun, 09/20/20 - 07:57 pm
ESMO
Roche
Tecentriq
triple negative breast cancer
Merck
Keytruda
ESMO: Where will Merck, Eisai take Keytruda-Lenvima next? Ovarian and colorectal cancer could be good options, data show
Fierce Pharma
Sun, 09/20/20 - 07:44 pm
Merck
Eisai
Keytruda
Lenvima
ovarian cancer
colorectal cancer
ESMO: Merck's Keytruda-chemo combo shows survival 'trend,' but can't top chemo in bladder cancer
Fierce Pharma
Sat, 09/19/20 - 09:11 pm
Merck
ESMO
bladder cancer
metastatic bladder cancer
Keytruda
ESMO: Alkermes' major I-O hope sees progress across early cancer tests
Fierce Biotech
Fri, 09/18/20 - 11:09 am
Alkermes
immuno-oncology
ESMO
ALKS 4230
Keytruda
Highlight Therapeutics trials second-line melanoma combo after immunotherapy fails
Pharmaforum
Wed, 09/2/20 - 10:49 am
Highlight Therapeutics
melanoma
BO-112
Keytruda
Merck
WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?
Fierce Pharma
Sun, 08/9/20 - 11:14 pm
Eli Lilly
Innovent Biologics
China
non-small cell lung cancer
Tyvyt
Merck
Keytruda
NovoCure, Merck Team Up on Phase II Lung Cancer Trial
BioSpace
Wed, 07/15/20 - 11:16 pm
Merck
Novocure
clinical trials
tumor treating fields
Keytruda
non-small cell lung cancer
FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
Endpoints
Wed, 07/8/20 - 10:43 am
Merck
FDA
complete response letter
Keytruda
Eisaid
Lenvima
hepatocellular carcinoma
Roche
Merck & Co’s Keytruda gets new colorectal cancer use after month-long FDA review
Pharmaforum
Tue, 06/30/20 - 10:53 am
Merck
Keytruda
FDA
colorectal cancer
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
Fierce Pharma
Thu, 06/25/20 - 08:36 pm
immuno-oncology
checkpoint inhibitors
Merck
Bristol-Meyers Squibb
COVID-19
Keytruda
Opidvo
Yervoy
Genentech
Tecentriq
AstraZeneca
Imfinzi
Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK
Fierce Pharma
Wed, 06/24/20 - 11:41 pm
Merck
Keytruda
FDA
squamous cell carcinoma
Sanofi
Regeneron
Libtayo
Merck eats the lunch Bristol Myers never served, winning TMB-based OK for Keytruda
Endpoints
Wed, 06/17/20 - 10:48 am
Merck
Keytruda
Bristol-Myers Squibb
FDA
biomarkers
accelerated approvals
cancer
TMB
Merck & Co’s Keytruda fails in first line bladder cancer
Pharmaforum
Wed, 06/10/20 - 10:51 am
Merck
Keytruda
bladder cancer
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
Fri, 06/5/20 - 10:30 am
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
ASCO: Merck's Keytruda doubles time to disease progression in certain colorectal cancer patients
Fierce Pharma
Thu, 05/28/20 - 11:10 pm
Merck
Keytruda
clinical trials
ASCO 2020
colorectal cancer
ASCO 2020 – first-line lung cancer focus
EP Vantage
Thu, 05/14/20 - 12:02 pm
Roche
Merck
Bristol-Myers Squibb
ASCO 2020
lung cancer
Keytruda
tiragolumab
Opdivo
Yervoy
ASCO: Is the PD-1 target behind Keytruda's small-cell miss? Merck exec says no
Fierce Pharma
Wed, 05/13/20 - 10:38 pm
ASCO 2020
Merck
Keytruda
extensive-stage small cell lung cancer
Merck grabs FDA green light for less-frequent Keytruda dosing regimen
Fierce Pharma
Wed, 04/29/20 - 10:55 am
Merck
FDA
Keytruda
Merck builds case for six-week Keytruda dosing as FDA starts review
Pharmaforum
Mon, 04/27/20 - 07:28 pm
Merck
Keytruda
AACR
FDA
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »